Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Cryolife Inc (CRY) Common Stock USD0.01

Sell:$23.45 Buy:$23.53 Change: $0.22 (0.93%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.22 (0.93%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.22 (0.93%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

CryoLife, Inc. (CryoLife), is a medical device company. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.

Contact details

1655 Roberts Blvd NW
United States
+1 (770) 4193355

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$926.45 million
Shares in issue:
39.31 million
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • James Mackin
    Chairman of the Board, President, Chief Executive Officer, Director
  • D. Ashley Lee
    Chief Financial Officer, Chief Operating Officer, Executive Vice President
  • Jean Holloway
    Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
  • John Davis
    Senior Vice President - Global Sales and Marketing
  • Amy Horton
    Chief Accounting Officer, Vice President
  • Dennis Maier
    Vice President - Operations
  • Matthew Getz
    Vice President - Human Resources
  • F. Peter Barthold
    Vice President - Research and Development
  • Scott Capps
    Vice President - Clinical Research

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.